Trademark: 86666115
Word
FUTURELYTICS
Status
Dead
Status Code
606
Status Date
Monday, May 20, 2019
Serial Number
86666115
Mark Type
4000
Filing Date
Wednesday, June 17, 2015
Published for Opposition
Tuesday, February 23, 2016
Abandoned Date
Monday, May 20, 2019

Trademark Owner History
Roche Molecular Systems, Inc. - Owner At Publication

Classifications
9 Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; downloadable computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
42 Data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely, of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to individuals' clinical responses to drug treatments and treatment regimes; providing scientific advise in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients, providing scientific information on individuals' genomic changes that contribute to a unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of individuals; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an online, non-downloadable computer software platform for purposes of storing and providing information about an individual's cancer profile and genomic changes to enable physicians and healthcare professionals to optimize treatment in clinical practice; providing an on-line searchable database in the field of clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information and biomarker information for scientific research purposes
FUTURE LYTICS

Trademark Events
May 20, 2019
Abandonment Notice E-Mailed - No Use Statement Filed
May 20, 2019
Abandonment - No Use Statement Filed
Jan 9, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 9, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 23, 2018
Notice Of Approval Of Extension Request Mailed
Oct 22, 2018
Extension 5 Granted
Oct 11, 2018
Extension 5 Filed
Oct 18, 2018
Case Assigned To Intent To Use Paralegal
Oct 11, 2018
Teas Extension Received
Mar 9, 2018
Notice Of Approval Of Extension Request Mailed
Mar 7, 2018
Extension 4 Granted
Mar 7, 2018
Extension 4 Filed
Mar 7, 2018
Teas Extension Received
Oct 18, 2017
Notice Of Approval Of Extension Request Mailed
Oct 16, 2017
Extension 3 Granted
Oct 16, 2017
Extension 3 Filed
Oct 16, 2017
Teas Extension Received
Apr 19, 2017
Notice Of Approval Of Extension Request Mailed
Apr 17, 2017
Extension 2 Granted
Apr 17, 2017
Extension 2 Filed
Apr 17, 2017
Teas Extension Received
Oct 14, 2016
Notice Of Approval Of Extension Request Mailed
Oct 12, 2016
Extension 1 Granted
Oct 12, 2016
Extension 1 Filed
Oct 12, 2016
Teas Extension Received
Apr 19, 2016
Noa Mailed - Sou Required From Applicant
Feb 23, 2016
Published For Opposition
Feb 3, 2016
Notice Of Publication
Jan 20, 2016
Approved For Pub - Principal Register
Jan 14, 2016
Teas/Email Correspondence Entered
Jan 13, 2016
Correspondence Received In Law Office
Jan 13, 2016
Teas Response To Office Action Received
Sep 3, 2015
Non-Final Action Mailed
Sep 2, 2015
Non-Final Action Written
Aug 31, 2015
Assigned To Examiner
Jun 24, 2015
Notice Of Pseudo Mark Mailed
Jun 23, 2015
New Application Office Supplied Data Entered In Tram
Jun 20, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24